scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1021212817 |
P356 | DOI | 10.1054/BJOC.2000.1682 |
P932 | PMC publication ID | 2363826 |
P698 | PubMed publication ID | 11259105 |
P5875 | ResearchGate publication ID | 12073749 |
P2093 | author name string | Tanaka M | |
Matsumoto K | |||
Nakamura T | |||
Kuba K | |||
Mizumoto K | |||
Maehara N | |||
P2860 | cites work | Molecular cloning and expression of human hepatocyte growth factor | Q24305558 |
Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells | Q31963959 | ||
Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer | Q33607176 | ||
Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts | Q33848365 | ||
Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocyte | Q33860778 | ||
Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement | Q34294357 | ||
Biology of pancreatic cancer | Q34394264 | ||
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor | Q35307866 | ||
Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met. | Q35753150 | ||
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis | Q35798481 | ||
Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients | Q36134982 | ||
Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells | Q36223889 | ||
The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis | Q36235637 | ||
Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition | Q36420063 | ||
Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network | Q36557528 | ||
Hepatocyte growth factor and invasion-stimulatory activity are induced in pleural fluid by surgery in lung cancer patients | Q36619723 | ||
The National Cancer Data Base report on pancreatic cancer | Q36799546 | ||
Fibroblast-mediated acceleration of human epithelial tumor growth in vivo | Q37657276 | ||
Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells | Q40896268 | ||
Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells | Q40993570 | ||
Does surgical stress cause tumor metastasis? | Q41101710 | ||
Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells | Q41129457 | ||
Scatter factor expression and regulation in human glial tumors | Q41184022 | ||
Regulation of scatter factor production via a soluble inducing factor | Q41438276 | ||
Effect of hepatocyte growth factor on cadherin-mediated cell-cell adhesion. | Q41563875 | ||
Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors | Q41565880 | ||
Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth | Q41596252 | ||
Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration | Q41641693 | ||
Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer | Q46602989 | ||
Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells | Q46722158 | ||
Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. | Q55314245 | ||
Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats | Q60034429 | ||
Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor | Q61857463 | ||
Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study | Q62065473 | ||
Pancreatic carcinoma | Q67734499 | ||
Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells | Q67862186 | ||
Increased levels of human hepatocyte growth factor in serum and peritoneal fluid after partial hepatectomy | Q70899153 | ||
Hepatocyte growth factor is a potent mitogen for normal human pancreas cells in vitro | Q71755093 | ||
Recurrence after resection for ductal adenocarcinoma of the pancreas | Q71973040 | ||
Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells | Q72178134 | ||
Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer | Q72571222 | ||
Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines | Q72785129 | ||
HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice | Q73299590 | ||
Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions | Q73555198 | ||
HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor | Q74121111 | ||
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis | Q74191318 | ||
Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-darby canine kidney epithelial cells | Q77472189 | ||
Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor | Q77768538 | ||
Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy | Q77894883 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pancreatic cancer | Q212961 |
P304 | page(s) | 864-873 | |
P577 | publication date | 2001-03-01 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells | |
P478 | volume | 84 |
Q38956369 | A DNA aptamer to c-Met inhibits cancer cell migration. |
Q41205527 | Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells |
Q37970379 | Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression |
Q33899938 | Biological approaches to therapy of pancreatic cancer |
Q64889128 | Cancer-Associated Fibroblasts Enhance Survival and Progression of the Aggressive Pancreatic Tumor Via FGF-2 and CXCL8. |
Q78819166 | Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production |
Q41137386 | Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stroma |
Q33867389 | Effects of adenoviral-mediated gene transduction of NK4 on proliferation, movement, and invasion of human colonic LS174T cancer cells in vitro |
Q36318551 | Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy |
Q40561060 | Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model. |
Q40708249 | Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer. |
Q43521896 | High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis. |
Q40203442 | Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma |
Q40704803 | Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice. |
Q80487795 | Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma |
Q28235183 | Met, metastasis, motility and more |
Q30838867 | PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration |
Q46845221 | Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival |
Q35739397 | Process of hepatic metastasis from pancreatic cancer: biology with clinical significance |
Q40568729 | Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effects. |
Q40669797 | Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line |
Q40749632 | SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma. |
Q73767192 | SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions |
Q34099443 | Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model |
Q40715924 | Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomas. |
Search more.